According to the research report, the global market for Quadrivalent Meningococcal Vaccine should grow from US$ 185 million in 2022 to US$ 245.2 million by 2029, with a CAGR of 5.9% for the period of 2023-2029.

Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.

The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.

This report studies and analyses global Quadrivalent Meningococcal Vaccine status and future trends, helps the client to determine the Quadrivalent Meningococcal Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Quadrivalent Meningococcal Vaccine, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Quadrivalent Meningococcal Vaccine market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Quadrivalent Meningococcal Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Quadrivalent Meningococcal Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Quadrivalent Meningococcal Vaccine key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Quadrivalent Meningococcal Vaccine key producing regions, capacity, production, and year over year growth

(6) Quadrivalent Meningococcal Vaccine industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Sanofi-Pasteur

Walvax

Chengdu Kanghua Biological Products Co., Ltd.

Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.

Zhejiang Tianyuan Biopharmaceutical Co., Ltd.

Beijing Institute of Biological Products Co., Ltd.

CanSino Biological Co., Ltd.

Hualan Biological Vaccine Co., Ltd.

Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

Market segment by Type, covers

Polysaccharide Vaccine

Conjugate Vaccine

Market segment by Application, can be divided into

Hospital

Clinic

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Quadrivalent Meningococcal Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Quadrivalent Meningococcal Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Quadrivalent Meningococcal Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Quadrivalent Meningococcal Vaccine, percent & CAGR, 2018-2029

Chapter 5: Quadrivalent Meningococcal Vaccine industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Quadrivalent Meningococcal Vaccine Definition

1.2 Global Quadrivalent Meningococcal Vaccine Market Size and Forecast

1.2.1 By Consumption Value, Global Quadrivalent Meningococcal Vaccine Market Size，2018-2029

1.2.2 By Sales Quantity, Global Quadrivalent Meningococcal Vaccine Market Size，2018-2029

1.2.3 Global Quadrivalent Meningococcal Vaccine Average Selling Price (ASP)，2018-2029

1.3 China Quadrivalent Meningococcal Vaccine Market Size and Forecast

1.3.1 By Consumption Value, China Quadrivalent Meningococcal Vaccine Market Size，2018-2029

1.3.2 By Sales Quantity, China Quadrivalent Meningococcal Vaccine Market Size，2018-2029

1.3.3 China Quadrivalent Meningococcal Vaccine Average Selling Price (ASP)， 2018-2029

1.4 Share of China Quadrivalent Meningococcal Vaccine Market with Respect to the Global Market

1.4.1 By Consumption Value, China Quadrivalent Meningococcal Vaccine Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China Quadrivalent Meningococcal Vaccine Market Share in Global, 2018-2029

1.4.3 Quadrivalent Meningococcal Vaccine Market Size: China VS Global, 2018-2029

1.5 Quadrivalent Meningococcal Vaccine Market Dynamics

1.5.1 Quadrivalent Meningococcal Vaccine Market Drivers

1.5.2 Quadrivalent Meningococcal Vaccine Market Restraints

1.5.3 Quadrivalent Meningococcal Vaccine Industry Trends

1.5.4 Quadrivalent Meningococcal Vaccine Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Quadrivalent Meningococcal Vaccine, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of Quadrivalent Meningococcal Vaccine, Global Market Share by Company, 2018-2023

2.3 Quadrivalent Meningococcal Vaccine Average Selling Price (ASP) by Company, 2018-2023

2.4 Global Quadrivalent Meningococcal Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Quadrivalent Meningococcal Vaccine Concentration Ratio

2.6 Global Quadrivalent Meningococcal Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Quadrivalent Meningococcal Vaccine Manufacturers Product Type

2.8 Head Office and Quadrivalent Meningococcal Vaccine Production Site of Key Manufacturer

2.9 Quadrivalent Meningococcal Vaccine Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Quadrivalent Meningococcal Vaccine, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of Quadrivalent Meningococcal Vaccine, China Market Share by Company, 2018-2023

3.3 China Quadrivalent Meningococcal Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Quadrivalent Meningococcal Vaccine Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global Quadrivalent Meningococcal Vaccine Capacity by Region

4.3 Global Quadrivalent Meningococcal Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global Quadrivalent Meningococcal Vaccine Production by Region, 2018-2029

4.5 Global Quadrivalent Meningococcal Vaccine Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Quadrivalent Meningococcal Vaccine Industry Chain

5.2 Quadrivalent Meningococcal Vaccine Upstream Analysis

5.2.1 Quadrivalent Meningococcal Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Quadrivalent Meningococcal Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Quadrivalent Meningococcal Vaccine Production Mode

5.6 Quadrivalent Meningococcal Vaccine Procurement Model

5.7 Quadrivalent Meningococcal Vaccine Industry Sales Model and Sales Channels

5.7.1 Quadrivalent Meningococcal Vaccine Sales Model

5.7.2 Quadrivalent Meningococcal Vaccine Typical Distributors

6 Sights by Type

6.1 Quadrivalent Meningococcal Vaccine Classification

6.1.1 Polysaccharide Vaccine

6.1.2 Conjugate Vaccine

6.2 By Type, Global Quadrivalent Meningococcal Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029

6.4 By Type, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029

6.5 By Type, Global Quadrivalent Meningococcal Vaccine Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 Quadrivalent Meningococcal Vaccine Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Quadrivalent Meningococcal Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029

7.4 By Application, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029

7.5 By Application, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029

8.3 By Region, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America Quadrivalent Meningococcal Vaccine & Forecasts, 2018-2029

8.4.2 By Country, North America Quadrivalent Meningococcal Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Quadrivalent Meningococcal Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Quadrivalent Meningococcal Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Quadrivalent Meningococcal Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029

9.3 By Country, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.4.2 By Type, U.S. Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.5.2 By Type, Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.6.2 By Type, China Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.7.2 By Type, Japan Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.8.2 By Type, South Korea Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.9.2 By Type, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.10.2 By Type, India Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Sanofi-Pasteur

10.1.1 Sanofi-Pasteur Company Information, Head Office, Market Area, and Industry Position

10.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Sanofi-Pasteur Company Profile and Main Business

10.1.5 Sanofi-Pasteur Recent Developments

10.2 Walvax

10.2.1 Walvax Company Information, Head Office, Market Area, and Industry Position

10.2.2 Walvax Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.2.3 Walvax Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Walvax Company Profile and Main Business

10.2.5 Walvax Recent Developments

10.3 Chengdu Kanghua Biological Products Co., Ltd.

10.3.1 Chengdu Kanghua Biological Products Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Chengdu Kanghua Biological Products Co., Ltd. Company Profile and Main Business

10.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments

10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.

10.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Profile and Main Business

10.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments

10.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.

10.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Profile and Main Business

10.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments

10.6 Beijing Institute of Biological Products Co., Ltd.

10.6.1 Beijing Institute of Biological Products Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Beijing Institute of Biological Products Co., Ltd. Company Profile and Main Business

10.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments

10.7 CanSino Biological Co., Ltd.

10.7.1 CanSino Biological Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 CanSino Biological Co., Ltd. Company Profile and Main Business

10.7.5 CanSino Biological Co., Ltd. Recent Developments

10.8 Hualan Biological Vaccine Co., Ltd.

10.8.1 Hualan Biological Vaccine Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Hualan Biological Vaccine Co., Ltd. Company Profile and Main Business

10.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments

10.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

10.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

10.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

10.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Profile and Main Business

10.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Quadrivalent Meningococcal Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Quadrivalent Meningococcal Vaccine Market Restraints

Table 3. Quadrivalent Meningococcal Vaccine Market Trends

Table 4. Quadrivalent Meningococcal Vaccine Industry Policy

Table 5. Global Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Quadrivalent Meningococcal Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Quadrivalent Meningococcal Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Quadrivalent Meningococcal Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Quadrivalent Meningococcal Vaccine Manufacturers Product Type

Table 13. Head Office and Quadrivalent Meningococcal Vaccine Production Site of Key Manufacturer

Table 14. Quadrivalent Meningococcal Vaccine Capacity of Major Manufacturers and Future Plan

Table 15. China Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Quadrivalent Meningococcal Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Quadrivalent Meningococcal Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Quadrivalent Meningococcal Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Quadrivalent Meningococcal Vaccine Production by Region, 2018-2023, (K Units)

Table 20. Global Quadrivalent Meningococcal Vaccine Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Quadrivalent Meningococcal Vaccine Upstream (Raw Materials)

Table 22. Global Quadrivalent Meningococcal Vaccine Typical Customers

Table 23. Quadrivalent Meningococcal Vaccine Typical Distributors

Table 24. By Type, Global Quadrivalent Meningococcal Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Quadrivalent Meningococcal Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Quadrivalent Meningococcal Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2018-2029

Table 34. Sanofi-Pasteur Company Information, Head Office, Market Area, and Industry Position

Table 35. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 36. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Sanofi-Pasteur Company Profile and Main Business

Table 38. Sanofi-Pasteur Recent Developments

Table 39. Walvax Company Information, Head Office, Market Area, and Industry Position

Table 40. Walvax Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 41. Walvax Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Walvax Company Profile and Main Business

Table 43. Walvax Recent Developments

Table 44. Chengdu Kanghua Biological Products Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 45. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 46. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Chengdu Kanghua Biological Products Co., Ltd. Company Profile and Main Business

Table 48. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments

Table 49. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 50. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 51. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 53. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments

Table 54. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 55. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 56. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 58. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments

Table 59. Beijing Institute of Biological Products Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 60. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 61. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Beijing Institute of Biological Products Co., Ltd. Company Profile and Main Business

Table 63. Beijing Institute of Biological Products Co., Ltd. Recent Developments

Table 64. CanSino Biological Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 65. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 66. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. CanSino Biological Co., Ltd. Company Profile and Main Business

Table 68. CanSino Biological Co., Ltd. Recent Developments

Table 69. Hualan Biological Vaccine Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 70. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 71. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Hualan Biological Vaccine Co., Ltd. Company Profile and Main Business

Table 73. Hualan Biological Vaccine Co., Ltd. Recent Developments

Table 74. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 75. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications, and Application

Table 76. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Profile and Main Business

Table 78. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments

List of Figures

Figure 1. Quadrivalent Meningococcal Vaccine Picture

Figure 2. Global Quadrivalent Meningococcal Vaccine Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Quadrivalent Meningococcal Vaccine Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Quadrivalent Meningococcal Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Quadrivalent Meningococcal Vaccine Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Quadrivalent Meningococcal Vaccine Sales Quantity (K Units) & (2018-2029)

Figure 7. China Quadrivalent Meningococcal Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Quadrivalent Meningococcal Vaccine Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Quadrivalent Meningococcal Vaccine Market Share of Global, 2018-2029

Figure 10. Global Quadrivalent Meningococcal Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2022

Figure 12. Global Quadrivalent Meningococcal Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Quadrivalent Meningococcal Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Quadrivalent Meningococcal Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 15. Quadrivalent Meningococcal Vaccine Industry Chain

Figure 16. Quadrivalent Meningococcal Vaccine Procurement Model

Figure 17. Quadrivalent Meningococcal Vaccine Sales Model

Figure 18. Quadrivalent Meningococcal Vaccine Sales Channels, Direct Sales, and Distribution

Figure 19. Polysaccharide Vaccine

Figure 20. Conjugate Vaccine

Figure 21. By Type, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 24. By Type, Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global Quadrivalent Meningococcal Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 26. Hospital

Figure 27. Clinic

Figure 28. By Application, Global Quadrivalent Meningococcal Vaccine Consumption Value, 2018-2029, US$ Million

Figure 29. By Application, Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2018-2029

Figure 30. By Application, Global Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 31. By Application, Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2018-2029

Figure 32. By Application, Global Quadrivalent Meningococcal Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 33. By Region, Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2018-2029

Figure 34. By Region, Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2018-2029

Figure 35. North America Quadrivalent Meningococcal Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 36. By Country, North America Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2022

Figure 37. Europe Quadrivalent Meningococcal Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 38. By Country, Europe Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2022

Figure 39. Asia Pacific Quadrivalent Meningococcal Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country/Region, Asia Pacific Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2022

Figure 41. South America Quadrivalent Meningococcal Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, South America Quadrivalent Meningococcal Vaccine Consumption Value Market Share, 2022

Figure 43. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. U.S. Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 45. By Type, U.S. Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 46. By Application, U.S. Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 47. Europe Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 50. China Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, China Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, China Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 53. Japan Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, Japan Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, Japan Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 56. South Korea Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, South Korea Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, South Korea Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 59. Southeast Asia Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 62. India Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, India Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, India Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 65. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 68. Research Methodology

Figure 69. Breakdown of Primary Interviews

Figure 70. Bottom-up and Top-down Approaches

Figure 71. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)